Ascorbigen — Rifabutin Toxicity Modifier by E. R. Pereverzeva, M. I. Treshchalin, I. D. Treshchalin

Subjects: Get full text

Hematological toxicity of [225Ac]Ac-PSMA-617 and [177Lu]Lu-PSMA-617 in RM1-PGLS syngeneic mouse model by Meryl Maria Vilangattil, Abir Swaidan, Jonathan Godinez, Marco F. Taddio, Johannes Czernin, Christine E. Mona, Giuseppe Carlucci

Subjects: Get full text

HEMATOTOXIC ADVERSE DRUG REACTIONS ASSOCIATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS AND CYTOTOXIC DRUGS IN THE TREATMENT OF GLIOBLASTOMA: A SYSTEMATIC REVIEW by I. A. Stepanov, M. A. Shameeva, D. B. Kruchinin, V. A. Byvaltsev, I. A. Shagdurova

Subjects: Get full text

Risk factors associated with high-dose methotrexate induced toxicities in primary central nervous system lymphoma by Wenshu Li, Wenshu Li, Sitian Zhang, Ruoyun Wu, Ruoyun Wu, Ying Li, Shifeng Wei, Shifeng Wei, Lin Fu, Xuefei Sun, Yuanbo Liu, Zhigang Zhao, Zhigang Zhao, Shenghui Mei, Shenghui Mei

Subjects: Get full text

Case Report: Influence of BRCA1 germline mutation on treatment-related morbidity of a non-seminomatous germ cell tumor patient by Bruno Griesler, Bruno Griesler, Susann Schulze, Thomas Kegel, Christine Dierks, Pablo Villavicencio-Lorini, Pablo Villavicencio-Lorini, Markus Eszlinger, Haifa Kathrin Al-Ali, Nadja Jaekel

Subjects: “…hematotoxicity…”
Get full text

Assessment of functional safety of blood forming organs in research of toxicological properties of medicinal products (Review). Part 1. Features of the hematopoietic organs of labo... by N. M. Faustova, A. E. Saloponova, M. V. Miroshnikov, M. N. Makarova, V. G. Makarov

Subjects: Get full text